The BPS Board Certified Oncology Pharmacist (BCOP)

program is a credential for pharmacists who have met the eligibility criteria below and who in their unique practice, involving an increasing number and complexity of drug therapies for treating and preventing cancer, manage cancer-related and drug-related adverse events or clinical situations not encountered in other disease states.

The purpose of the BCOP program is to validate that the pharmacist has the advanced knowledge and experience to optimize outcomes for patients with malignant diseases by:

• Recommending, designing, implementing, monitoring, and modifying pharmacotherapeutic plans;

• Reducing medication errors; and

• Recognizing and responding to adverse physical and emotional issues that may arise during treatment and when providing education and counseling.